[HTML][HTML] Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

AT Levin, WP Hanage, N Owusu-Boaitey… - European journal of …, 2020 - Springer
Determine age-specific infection fatality rates for COVID-19 to inform public health policies
and communications that help protect vulnerable age groups. Studies of COVID-19 …

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

C Schultheiß, E Willscher, L Paschold, C Gottschick… - Cell Reports …, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review

R Grant, T Dub, X Andrianou, H Nohynek… - BMJ open, 2021 - bmjopen.bmj.com
Objectives We aimed to review SARS-CoV-2 seroprevalence studies conducted in Europe
to understand how they may be used to inform ongoing control strategies for COVID-19 …

COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries

LP Wong, H Alias, M Danaee, J Ahmed… - Infectious diseases of …, 2021 - Springer
Background The availability of various types of COVID-19 vaccines and diverse
characteristics of the vaccines present a dilemma in vaccination choices, which may result in …

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

A Haveri, N Ekström, A Solastie, C Virta… - European Journal of …, 2021 - Wiley Online Library
Most subjects develop antibodies to SARS‐CoV‐2 following infection. In order to estimate
the duration of immunity induced by SARS‐CoV‐2 it is important to understand for how long …

Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a …

F Carrat, X De Lamballerie, D Rahib… - International journal …, 2021 - academic.oup.com
Background We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodies in May–
June 2020 after the first lockdown period in adults living in three regions in France and to …

Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA. 2 wave in Geneva, Switzerland: a population-based …

ME Zaballa, J Perez-Saez, C de Mestral… - The Lancet Regional …, 2023 - thelancet.com
Background More than two years into the COVID-19 pandemic, most of the population has
developed anti-SARS-CoV-2 antibodies from infection and/or vaccination. However, public …

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance

S Le Vu, G Jones, F Anna, T Rose, JB Richard… - Nature …, 2021 - nature.com
Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring
the course and extent of the COVID-19 epidemic. Here, we report estimated seroprevalence …

[HTML][HTML] SARS-CoV-2 seroprevalence in germany: a population-based sequential study in seven regions

D Gornyk, M Harries, S Glöckner… - Deutsches ärzteblatt …, 2021 - ncbi.nlm.nih.gov
Background Until now, information on the spread of SARS-CoV-2 infections in Germany has
been based mainly on data from the public health offices. It may be assumed that these data …

Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study

F Carrat, X de Lamballerie, D Rahib, H Blanche… - MedRxiv, 2020 - medrxiv.org
Background To estimate the seroprevalence of SARS-CoV-2 infection in May-June 2020
after the lockdown in adults living in three regions in France and to identify the associated …